Concepedia

Long-acting Bronchodilators

Long-Acting Bronchodilators is a pharmacological agent that belongs to the class of bronchodilatory drugs and is distinguished by its sustained activity over an extended duration, typically providing bronchodilation for 12 hours or more following administration.

285

Publications

20.7K

Citations

1.3K

Authors

588

Institutions

Publications per year

2017–2026

63

Parents

Publications

285

Dupilumab in Persistent Asthma with Elevated Eosinophil Levels

Sally E. Wenzel, Linda Ford, David S. Pearlman et al. · New England Journal of Medicine · 2013 · 1.3K citations · Full text

, , +17

Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD

Denis E. O’Donnell, Thomas Flüge, Fronke Gerken et al. · European Respiratory Journal · 2004 · 859 citations

, , +17

The Prevention of Chronic Obstructive Pulmonary Disease Exacerbations by Salmeterol/Fluticasone Propionate or Tiotropium Bromide

Jadwiga A. Wedzicha, Peter M.A. Calverley, Terence Seemungal et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 843 citations

, , +17

Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD

Claus Vogelmeier, Bettina Hederer, Thomas Glaab et al. · New England Journal of Medicine · 2011 · 681 citations · Full text

, , +15

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Shawn D. Aaron, Katherine L. Vandemheen, Dean Fergusson et al. · PubMed · 2007 · 654 citations

, , +17

1–5 of 285

Authors

1.3K

  1. DP
    David Price

    University of Aberdeen, United Kingdom

    9 publications · 345 citations

    9

    h-index

  2. PM
    Peter M.A. Calverley

    University of Liverpool, United Kingdom

    7 publications · 2.3K citations

    7

    h-index

  3. EK
    Edward Kerwin

    Clinical Research Institute, United States

    6 publications · 481 citations

    6

    h-index

  4. SS
    Samy Suissa

    McGill University, Canada

    6 publications · 442 citations

    6

    h-index

  5. JA
    Jadwiga A. Wedzicha

    Imperial College London, United Kingdom

    5 publications · 948 citations

    5

    h-index

1–5 of 1.3K

Institutions

588

  1. Boehringer Ingelheim (Germany)

    Ingelheim, Germany

    11 h-index

    25 publications

    5.2K citations

  2. Novartis (Switzerland)

    Basel, Switzerland

    10 h-index

    58 publications

    5.1K citations

  3. Research Triangle Park Foundation

    Durham, United States

    10 h-index

    24 publications

    2.4K citations

  4. GlaxoSmithKline (United States)

    Philadelphia, United States

    9 h-index

    16 publications

    679 citations

  5. Boehringer Ingelheim (United States)

    Ridgefield, United States

    8 h-index

    19 publications

    4.1K citations

  6. McMaster University

    Hamilton, Canada

    8 h-index

    16 publications

    978 citations

  7. GlaxoSmithKline (United Kingdom)

    London, United Kingdom

    8 h-index

    16 publications

    2K citations

  8. University of Colorado Denver

    Denver, United States

    7 h-index

    8 publications

    1.1K citations

1–8 of 588

Venues

  1. International Journal of COPD

    27 publications · 841 citations

    19

    h-index

  2. Respiratory Research

    RR · 17 publications · 1K citations

    16

    h-index

  3. European Respiratory Journal

    14 publications · 2.2K citations

    14

    h-index

  4. Respiratory Medicine

    14 publications · 323 citations

    13

    h-index

  5. PubMed

    Repository · 14 publications · 930 citations

    12

    h-index

1–5